Melek Yalcin Koc

Dr. Melek Yalcin Koc


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2025 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
MKMelek Yalcin Koc
Melek Yalcin Koc
MYMehmet Aykut Yildirim
Mehmet Aykut Yildirim
STSuleyman Sakir Tavli
Suleyman Sakir Tavli
ADAbdullah Gürhan Duyan
Abdullah Gürhan Duyan
To investigate the relationships between red cell distribution width (RDW), other inflammation-related markers and clinical features with the clinical and radiological severity of diverticulitis. This retrospective cohort study included 250 patients diagnosed with acute diverticulitis. Radiological diverticulitis severity was determined by the Hinchey classification. Clinical diverticulitis severity was determined based on the treatment applied (invasive versus conservative/medical treatment). High platelet count (p = 0.001) and high CRP (p < 0.001) were independently associated with the Hinchey Class II-IV. Need for invasive treatment was independently associated with presence of Hinchey stage II-IV (p < 0.001) and high (> 13.75) RDW (p < 0.001). With a cut-off value of > 13.75, RDW was able to predict patients requiring invasive treatment [Sensitivity = 75.86%, Specificity = 63.87%, AUC (95% CI) = 0.657 (0.580–0.734), p < 0.001]. RDW, which is an inexpensive and readily-available parameter, may be a supportive measure in the prediction of the clinical severity of diverticulitis. Together with other clinical and laboratory data, RDW could help identify patients with worse prognosis, facilitating appropriate decisions and precautions in their management.

1 January 2025 in Open Medicine
Verified
Journal Article
Open access
PDF file
RKRamazan Saygin Kerimoglu
Ramazan Saygin Kerimoglu
SKSuleyman Kargin
Suleyman Kargin
ASAysegul Yilmaz Sirit
Aysegul Yilmaz Sirit
MKMelek Yalcin Koc
Melek Yalcin Koc
ADAbdullah Gürhan Duyan
Abdullah Gürhan Duyan
Objectives: Obesity and gallbladder stone disease are strongly connected conditions. Nonetheless, the concomitant performance of cholecystectomy alongside sleeve gastrectomy remains contentious in individuals with asymptomatic gallstones. This study examines the impact of cholecystectomy timing on weight loss following sleeve gastrectomy. Methods: A retrospective assessment was conducted on the records of 94 patients who underwent bariatric surgery from 2021 to 2025. The effect on weight loss (% EWL), insulin resistance, and other metabolic parameters was evaluated in patients who underwent concomitant cholecystectomy with sleeve gastrectomy, those who had cholecystectomy six months post-surgery, and those who received cholecystectomy prior to sleeve gastrectomy. Results: Out of 94 patients, 29 (30.8 %) received concomitant cholecystectomy. It was established that patients who received late cholecystectomy experienced reduced complication rates, shorter hospital stays, and decreased operation times compared to other groups. Fasting glucose and insulin resistance levels were significantly reduced in the late group at the 3rd and 6th months, but they diminished at the 6th month in the contemporaneous group (p<0.05). The augmentation in EWL% was markedly superior in the late group relative to the other groups commencing from the third month (p<0.05). Conclusions: Postponing the treatment of asymptomatic gallbladder disease after sleeve gastrectomy is both safe and may yield beneficial effects on weight reduction and insulin sensitivity.